QUOTE AND NEWS
Benzinga  Dec 18  Comment 
• ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) CEO Dr. Laurence Cooper believes that the company’s cell programming languages set it apart from other cancer researchers. • The company’s Sleeping Beauty platform allows for T cell modification...
Benzinga  Dec 7  Comment 
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical company focused on new cancer immunotherapies, today announced that results from its CD19-specific CAR T-cell therapy programs were presented at the 57th American Society of Hematology...
Motley Fool  Dec 4  Comment 
Chief Operating Officer Caesar Belbel exercised options and sold shares worth nearly $2 million.
Motley Fool  Nov 11  Comment 
The biotech's stock rocketed higher in October. Should investors jump on this high-flying biotech stock right now?
Benzinga  Nov 10  Comment 
Ocata Therapeutics Inc (NASDAQ: OCAT) shares touched a new 52-week high of $8.425 after the company agreed to be acquired by ASTELLAS PHARMA INC (OTC: ALPMY) for $8.50 per share. Owens & Minor, Inc. (NYSE: OMI) shares reached a new 52-week...
GenEng News  Sep 29  Comment 
Intrexon is joining forces with Ziopharm Oncology in a collaboration that will concentrate on the treatment and prevention of graft-versus-host disease (GvHD). GvHD is a major complication of allogeneic hematopoietic stem-cell transplantation...
Benzinga  Sep 28  Comment 
Intrexon Corporation (NYSE: XON), a leader in synthetic biology, announced today it has formed a new Exclusive Channel Collaboration (ECC) with ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical company focused on new cancer...





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki